LOKVULOW SIGNALFINANCIAL10-Q

LOKVU's quarterly 10-Q update shows routine cash burn with stable trust account balance as the SPAC continues searching for a business combination target.

The filing represents a standard quarterly update for a pre-combination SPAC with no operational activity. While operating cash outflows increased modestly quarter-over-quarter, this reflects normal administrative expenses for a company in the target identification phase.

Comparing 2025-11-12 vs 2025-08-13View on EDGAR →
FINANCIAL ANALYSIS

LOKVU's financial position remained relatively stable with cash and equivalents declining 10.5% to $1.9M due to ongoing operating expenses, while the trust account grew slightly to $236.8M. Operating cash burn increased to -$660K from -$432K, but net losses actually improved 50% due to higher investment income from the trust account. The overall picture reflects a typical SPAC burning through working capital for administrative costs while the bulk of investor funds remain preserved in trust earning investment returns.

FINANCIAL STATEMENT CHANGES
Operating Cash Flow
Cash Flow
-52.9%
-$432K-$660K

Operating cash flow fell 52.9% — earnings quality concerns; investigate working capital changes and non-cash items.

Net Income
P&L
+50.1%
-$4.2M-$2.1M

Net income grew 50.1% — bottom-line growth signals improving overall business health.

Current Liabilities
Balance Sheet
+18.7%
$317K$376K

Current liabilities rose 18.7% — increased short-term obligations, watch current ratio.

Current Assets
Balance Sheet
-11.1%
$2.3M$2.1M

Current assets declined 11.1% — monitor working capital adequacy and short-term liquidity.

Cash & Equivalents
Balance Sheet
-10.5%
$2.2M$1.9M

Cash decreased 10.5% — monitor burn rate and upcoming capital needs.

LANGUAGE CHANGES
NEW — 2025-11-12
PRIOR — 2025-08-13
ADDED
Financial Statements 1 Condensed Balance Sheets as of September 30, 2025 (Unaudited) and December 31, 2024 1 Condensed Statements of Operations for the Three and Nine Months Ended September 30, 2025 (Unaudited) 2 Condensed Statements of Changes in Shareholders Equity (Deficit) for the Three and Nine Months Ended September 30, 2025 (Unaudited) 3 Condensed Statement of Cash Flows for the Nine Months Ended September 30, 2025 (Unaudited) 4 Notes to Condensed Financial Statements (Unaudited) 5 Item 2.
As of September 30, 2025, the Company had not commenced any operations.
Liquidity and Capital Resources As of September 30, 2025, the Company had cash and cash equivalents of $ 1,949,131 .
As of September 30, 2025, no such Working Capital Loans were outstanding.
The Company had $ 1,949,131 and $0 in cash and cash equivalents as of September 30, 2025 and December 31, 2024, respectively.
As of September 30, 2025, the assets held in the Trust Account of $ 236,758,340 were held in money market funds.
For the three and nine months ended September 30, 2025, the Company incurred and paid $ 52,500 and $ 122,500 in fees for these services, respectively.
V NOTES TO CONDENSED FINANCIAL STATEMENTS SEPTEMBER 30, 2025 (Unaudited) The Company s CODM has been identified as the Chief Financial Officer , who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance.
Management s Discussion and Analysis of Financial Condition and Results of Operations Cautionary Note Regarding Forward-Looking Statements All statements other than statements of historical fact included in this Report including, without limitation, statements under this Item regarding our financial position, possible Business Combination and the financing thereof, and related matters, and the plans and objectives of Management for future operations, are forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act.
We have based these forward-looking statements on our Management s current expectations and projections about future events, as well as assumptions made by, and information currently available to, our Management.
REMOVED
Financial Statements 1 Condensed Balance Sheets as of June 30, 2025 (Unaudited) and December 31, 2024 1 Condensed Statements of Operations for the Three and Six Months Ended June 30, 2025 (Unaudited) 2 Condensed Statements of Changes in Shareholders Deficit for the Three and Six Months Ended June 30, 2025 (Unaudited) 3 Condensed Statement of Cash Flows for the Six Months Ended June 30, 2025 (Unaudited) 4 Notes to Condensed Financial Statements (Unaudited) 5 Item 2.
As of June 30, 2025, the Company had not commenced any operations.
Liquidity and Capital Resources As of June 30, 2025, the Company had cash and cash equivalents of $ 2,177,539 .
As of June 30, 2025, no such Working Capital Loans were outstanding.
The Company had $ 2,177,539 and $0 in cash and cash equivalents as of June 30, 2025 and December 31, 2024, respectively.
As of June 30, 2025, the assets held in the Trust Account of $ 234,310,386 were held in money market funds.
For the three and six months ended June 30, 2025, the Company incurred and paid $ 52,500 in fees for these services.
V NOTES TO CONDENSED FINANCIAL STATEMENTS JUNE 30, 2025 (Unaudited) The Company s chief operating decision maker has been identified as the Chief Financial Officer ( CODM ), who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance.
Management s Discussion and Analysis of Financial Condition and Results of Operations Cautionary Note Regarding Forward-Looking Statements All statements other than statements of historical fact included in this Report including, without limitation, statements under this Item regarding our financial position, business strategy and the plans and objectives of Management for future operations, are forward-looking statements.
For the three months ended June 30, 2025, we had a net income of $2,098,161, which consists of interest income on marketable securities held in the Trust Account of $2,442,453 and operating costs of $344,292.
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →